Synthesis, Structural Elucidation and α-Glucosidase Inhibitory Activity of New Hydrazide Derivatives
Öz
Diabetes mellitus (DM) is a chronic and progressive metabolic disorder affecting over 422 million people globally. It arises from insufficient insulin production or the inability of cells to respond to insulin, leading to disruptions in carbohydrate, fat, and protein metabolism. Over time, DM can result in severe complications such as cardiovascular diseases, kidney failure, and vision loss. Effective management of DM includes therapeutic strategies aimed at stabilizing blood glucose levels. Among these, α-glucosidase enzyme inhibitors play a crucial role by slowing carbohydrate digestion and reducing postprandial blood glucose spikes. In this study, new hydrazide derivatives linked to non-steroidal anti-inflammatory drugs (NSAIDs) were synthesized and evaluated as potential α-glucosidase enzyme inhibitors. Structural characterization of these derivatives was performed using techniques such as ¹H-NMR, FTIR, and mass spectrometry (MS). All of these compounds were tested in vitro for their α-glucosidase enzyme inhibition activity. Among the synthesized derivatives, ethyl 2-{3-[3-(trifluoromethyl)anilino]benzoyl}hydrazine-1-carboxylate (compound 3d), an etofenamate derivative, revealed the highest inhibitory potential with IC50 values of 188.30±0.1 μg mL-1 when compared with standard acarbose having IC50 value 190.70±2.05 μg mL-1. These findings highlight the potential of NSAID-linked hydrazide derivatives as promising candidates for the development of novel DM therapies.
Anahtar Kelimeler
Carboxylate, Diabetes Mellitus, Glucosidase, Hydrazide, NSAID
Destekleyen Kurum
TUBITAK 2209-A
Proje Numarası
1919B012324778
Kaynakça
- Aboul-Fadl, T., Abdel-Aziz, H. A., Kadi, A., Bari, A., Ahmad, P., Al-Samani, T., & Ng, S.W. (2011). Microwave-assisted one-step synthesis of fenamic acid hydrazides from the corresponding acids. Molecules, 16(5), 3544-3551. https://doi.org/10.3390/molecules16053544
- Alam, A., Ali, M., Rehman, N. U., Ullah, S., Halim, S. A., Latif, A., Zainab, Khan, A., Ullah, O., Ahmad, S., Al-Harrasi, A., & Ahmad, M. (2022). Bio-oriented synthesis of novel (S)-flurbiprofen clubbed hydrazone schiff’s bases for diabetic management: In vitro and in silico studies. Pharmaceuticals, 15(6), 672. https://doi.org/10.3390/ph15060672
- Antar, S. A., Ashour, N. A., Sharaky, M., Khattab, M., Ashour, N. A., Zaid, R. T., Roh, E. J., Elkamhawy, A., & Al-Karmalawy, A. A. (2023). Diabetes mellitus: Classification, mediators, and complications; A gate to identify potential targets for the development of new effective treatments. Biomedicine & Pharmacotherapy, 168, 115734. https://doi.org/10.1016/j.biopha.2023.115734
- Aydın, S., Kaushik-Basu, N., Arora, P., Basu, A., Nichols, D., Talele, T. T., Akkurt, M., Çelik, İ., Büyükgüngör, O., & Küçükgüzel, Ş. G. (2013). Microwave assisted synthesis of some novel Flurbiprofen hydrazidehydrazones as anti-HCV NS5B and anticancer agents. Marmara Pharmaceutical Journal, 17(1), 26-34.
- Aydın, S., Kaushik-Basu, N., Özbaş-Turan, S., Akbuğa, J., Tiber, P. M., Orun, O., Gurukumar, K. R., Basu, A., & Küçükgüzel, Ş. G. (2014). Synthesis of 1-aroyl-3 , 5-dimethyl-1H-pyrazoles as Anti-HCV and Anticancer Agents. Letters in Drug Design & Discovery, 11(2), 121-131. https://doi.org/10.2174/15701808113109990069
- Dabhi, A. S., Bhatt, N. R., & Shah, M. J. (2013). Voglibose: an alpha glucosidase inhibitor. Journal of Clinical and Diagnostic Research : JCDR, 7(12), 3023-3027. https://doi.org/10.7860/JCDR/2013/6373.3838
- Das, A. K., Biswas, S., Pal, A., Manna, S. S., Sardar, A., Mondal, P. K., Sahoo, B., Pathak, B., & Mandal, S. (2024). A thiolated copper-hydride nanocluster with chloride bridging as a catalyst for carbonylative C–N coupling of aryl amines under mild conditions: a combined experimental and theoretical study. Nanoscale, 16, 3583-3590. https://doi.org/10.1039/D3NR05912J
- Daud, S., Abid, O. R., Sardar, A., Shah, B. A., Rafiq, M., Wadood, A., Ghufran, M., Rehman, W., Wahab, Z., Iftikhar F., Sultana, R., Daud, H., & Niaz, B. (2022). Design, synthesis, in vitro evaluation, and docking studies on ibuprofen derived 1,3,4-oxadiazole derivatives as dual α-glucosidase and urease inhibitors. Medicinal Chemistry Research, 31(2), 316-336. https://doi.org/10.1007/s00044-021-02814-6
- Daud, S., Abid, O. R, Rehman, W., Sardar, A., Alanazi, M. M., Rasheed, L., Ejaz, S. A., Fayyaz, A., Shah, B.A., & Maalik, A. (2024). Exploring the potential of new mefenamic acid derivatives as α-glucosidase inhibitors: Structure-activity relationship, in-vitro and in-silico studies. Journal of Molecular Structure, 1316, 138812. https://doi.org/10.1016/j.molstruc.2024.138812
- Dirir, A. M., Daou, M., Yousef, A. F., & Yousef, L. F. (2022). A review of alpha-glucosidase inhibitors from plants as potential candidates for the treatment of type-2 diabetes. Phytochemistry Reviews : Proceedings of the Phytochemical Society of Europe, 21(4), 1049-1079. https://doi.org/10.1007/s11101-021-09773-1